Amazon buys Google backed One Medical for USD 3.9 billion

One Medical went public in 2020 and was backed by Google and others as a startup.;

Published On 2022-07-22 08:30 GMT | Update On 2022-07-22 08:30 GMT

San Francisco: Amazon on Thursday announced it has acquired primary healthcare organisation One Medical for approximately $3.9 billion, as the e-commerce giant steps up efforts to reinvent healthcare in digital and virtual era.

One Medical combines in-person care in inviting offices across the country with digital health and virtual care services, making it easier for patients to schedule appointments, renew prescriptions, access up-to-date health records, and advance health outcomes.

"Booking an appointment, waiting weeks or even months to be seen, taking time off work, driving to a clinic, finding a parking spot, waiting in the waiting room then the exam room for what is too often a rushed few minutes with a doctor, then making another trip to a pharmacy - we see lots of opportunity to both improve the quality of the experience and give people back valuable time in their days," said Neil Lindsay, SVP of Amazon Health Services.

"Together with One Medical's human-centered and technology-powered approach to health care, "we believe we can and will help more people get better care, when and how they need it," he said in a statement.

One Medical went public in 2020 and was backed by Google and others as a startup.

"There is an immense opportunity to make the health care experience more accessible, affordable, and even enjoyable for patients, providers, and payers. We look forward to innovating and expanding access to quality healthcare services, together," said Amir Dan Rubin, One Medical CEO.

Amazon will acquire One Medical for $18 per share in an all-cash transaction valued at approximately $3.9 billion, including One Medical's net debt.

The completion of the transaction is subject to customary closing conditions, including approval by One Medical's shareholders and regulatory approval.

Once the transaction is through, Rubin will remain as CEO of One Medical, said the company.

Article Source : IANS

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Amazon buys Google backed One Medical for USD 3.9 billion

One Medical went public in 2020 and was backed by Google and others as a startup.;

Similar News

AstraZeneca's Proposal to Increase Sample Size in Zibotentan-Dapagliflozin Global Trial Gets SEC Nod

Govt Allows Stickering, Orders New MRPs Post GST Reduction, AiMeD Welcomes Directive

Sun Pharma Secures Interim Court Relief In URSOCOL Trademark Dispute

Nellore Horror: 21-year-old B.Pharm student stabbed to death

Upcoming Una Bulk Drug Park receives environmental clearance

CDSCO Panel Nod To Phase I Clinical Trial of Anticancer Drug Bevacizumab by Jeevan Scientific

Orissa HC Seeks Govt Roadmap on Advanced Blood Testing Technology

AstraZeneca Faces NPPA Heat Over Symbicort Pricing, Slapped Rs 60 Crore Showcause Notice